#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency Pleural mesothelioma malignant Systemic lupus erythematosus Cerebral amyloid angiopathy Biliary cancer metastatic B-cell lymphoma Immune-mediated myasthenia gravis Lymphoma Bronchopulmonary dysplasia Infection in an immunocompromised host Autoimmune demyelinating disease Neuronal ceroid lipofuscinosis Oesophageal squamous cell carcinoma stage II Ependymoma Amyloidosis More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Treatment Haemophagocytic lymphohistiocytosis – Life with Disease Focal segmental glomerulosclerosis – Treatment Choroid melanoma Alport’s syndrome – Treatment Skin angiosarcoma – Trials in Disease Haemophilia – Diagnostics Chronic granulomatous disease Leiomyosarcoma SAPHO syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Sulfate Mk-0482 Water For Injections AUROCELL-TX Olorofim Ifosfamide Lna043 Brentuximab Vedotin Zopiclone Darolutamide Human Coagulation Factor Ix Eribulin Mesylate Azd0901 Ivospemin Tolvaptan Triptorelin Acetate Cl-Ad-Msc-002 Clopidogrel Pasireotide Diaspartate Avelumab More therapies…

    Learn about Your Condition

    Trigeminal neuralgia Electrocorticogram Muscle hypertrophy Peritonitis Dyslipidaemia Post procedural oedema Drug dependence Inclusion body myositis Infant sedation Osteoporosis postmenopausal Neonatal asphyxia Exposure via breast milk Transient ischaemic attack Cold type haemolytic anaemia Developmental hip dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immunodeficiency common variable

  • A Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Leniolisib Phosphate
    Spain

  • Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Selective polysaccharide antibody deficiency
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Human Normal Immunoglobulin (Iv)
    The Netherlands

  • Trial of Ataluren for Severe Common Variable Immunodeficiency with Autoimmunity in Patients with LRBA Deficiency

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ataluren
    Belgium

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!